Abstract |
Inhibitors of histone deacetylases (HDAC) are currently developed for the treatment of cancer. These include compounds with a sulfur containing head group like depsipeptide, alkylthiols, thiocarboxylates, and trithiocarbonates with a carbonyl group in the alpha-position. In the present investigation, we report on the synthesis and comprehensive SAR analysis of HDAC inhibitors bearing a tri- or dithiocarbonate motif. Such trithiocarbonates are readily accessible from either preformed or in situ prepared alpha-halogenated methylaryl ketones. A HDAC isotype selectivity and a substrate competitive mode-of-action is shown for defined analogues. Exploration of the head group showed the necessity of the dithio-alpha-carbonyl motif for potent HDAC inhibition. Highly potent, substrate competitive HDAC6 selective inhibitors were identified (12ac:IC 50 = 65 nM and K i = 110 nM). Trithiocarbonate analogues with an aminoquinoline-substituted pyridinyl-thienoacetyl cap demonstrate a cytotoxicity profile and potency comparable to that of suberoylanilide hydroxamic acid (SAHA) as an approved cancer drug.
|
Authors | Florian Dehmel, Steffen Weinbrenner, Heiko Julius, Thomas Ciossek, Thomas Maier, Thomas Stengel, Kamal Fettis, Carmen Burkhardt, Heike Wieland, Thomas Beckers |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 51
Issue 13
Pg. 3985-4001
(Jul 10 2008)
ISSN: 1520-4804 [Electronic] United States |
PMID | 18558669
(Publication Type: Journal Article)
|
Chemical References |
- Enzyme Inhibitors
- Histone Deacetylase Inhibitors
- Histones
- Isoenzymes
- Thiones
- Histone Deacetylases
- trithiocarbonic acid
|
Topics |
- Acetylation
- Cell Cycle
(drug effects)
- Cell Survival
(drug effects)
- Enzyme Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Histone Deacetylase Inhibitors
- Histone Deacetylases
(metabolism)
- Histones
(metabolism)
- Humans
- Isoenzymes
(antagonists & inhibitors, metabolism)
- Kinetics
- Molecular Structure
- Structure-Activity Relationship
- Thiones
(chemical synthesis, chemistry, pharmacology)
|